Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab
Home
Publications
The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab
The clinical importance of dosimetry in radioimmunotherapy with tositumomab and iodine I 131 tositumomab
Author:
RW
Richard L. Wahl
Richard L. Wahl
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 April 2003
journal article
review article
Published by
Elsevier
in
Seminars in Oncology
Vol. 30
(2E)
,
31-38
DOI:
10.1053/sonc.2003.23799
PMID:
12728405
Abstract
No abstract available
Keywords
TOSITUMOMAB RADIOIMMUNOTHERAPY
TOSITUMOMAB
CORIXA CORP
PROMISING EMERGING
EMERGING THERAPY
ULTIMATELY PROVE
RADIOIMMUNOTHERAPY
SOUTH SAN
SAN FRANCISCO
RIT
Cited
Cited by 53 articles
Scroll to top